Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Galactostatin is a chemical compound that belongs to the class of glycosidase inhibitors. It is known for its ability to inhibit the enzyme α-galactosidase, which is involved in the metabolism of complex carbohydrates such as galactose-containing substrates. By inhibiting this enzyme, galactostatin can interfere with the breakdown of certain carbohydrates in the body, potentially leading to altered metabolic processes. Its potential applications in research and medicine for studying carbohydrate metabolism and related diseases make it a promising candidate for further investigation.

107537-94-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 107537-94-0 Structure
  • Basic information

    1. Product Name: GALACTOSTATIN
    2. Synonyms: GALACTONOJIRIMYCIN;GALACTOSTATIN;5-AMINO-5-DEOXY-D-GALACTOPYRANOSE;6-(HYDROXYMETHYL)-2,3,4,6-PEPERIDINETETROL;5-Amino-5-deoxy-D-galactopyranose=Galactostatin;Galactonojirimycin,6-(Hydroxymethyl)-2,3,4,6-peperidinetetrol;5-amino-5-deoxygalactopyranose;5-O-Aza-D-galactopyranose
    3. CAS NO:107537-94-0
    4. Molecular Formula: C6H13NO5
    5. Molecular Weight: 179.17
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 107537-94-0.mol
  • Chemical Properties

    1. Melting Point: 93-95 °C (decomp)
    2. Boiling Point: 394.3 °C at 760 mmHg
    3. Flash Point: 214.3 °C
    4. Appearance: /
    5. Density: 1.643 g/cm3
    6. Vapor Pressure: 7.48E-08mmHg at 25°C
    7. Refractive Index: 1.634
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. PKA: 13.46±0.70(Predicted)
    11. CAS DataBase Reference: GALACTOSTATIN(CAS DataBase Reference)
    12. NIST Chemistry Reference: GALACTOSTATIN(107537-94-0)
    13. EPA Substance Registry System: GALACTOSTATIN(107537-94-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 107537-94-0(Hazardous Substances Data)

107537-94-0 Usage

Uses

Used in Research Applications:
Galactostatin is used as a research tool for studying the role of α-galactosidase in carbohydrate metabolism and its implications in various diseases. It helps researchers understand the effects of inhibiting this enzyme on metabolic processes and the potential therapeutic benefits of such inhibition.
Used in Pharmaceutical Development:
Galactostatin is used as a potential therapeutic agent for conditions such as Fabry disease, where the inhibition of α-galactosidase is beneficial. By targeting this enzyme, galactostatin may help manage the symptoms and progression of the disease, although further research is needed to fully understand its effects and potential applications.
Used in Drug Discovery:
Galactostatin is used in drug discovery efforts to identify new compounds with similar inhibitory properties against α-galactosidase. This can lead to the development of novel therapeutic agents for treating diseases related to carbohydrate metabolism and other conditions where α-galactosidase inhibition may be beneficial.
Used in Metabolic Disease Treatment:
Galactostatin is used as a potential treatment for metabolic diseases that involve the dysregulation of carbohydrate metabolism. By inhibiting α-galactosidase, it may help regulate the breakdown of complex carbohydrates and improve the overall metabolic health of patients.

Check Digit Verification of cas no

The CAS Registry Mumber 107537-94-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,5,3 and 7 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 107537-94:
(8*1)+(7*0)+(6*7)+(5*5)+(4*3)+(3*7)+(2*9)+(1*4)=130
130 % 10 = 0
So 107537-94-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO5/c8-1-2-3(9)4(10)5(11)6(12)7-2/h2-12H,1H2/t2-,3+,4+,5-,6?/m1/s1

107537-94-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (3R,4S,5S,6R)-6-(hydroxymethyl)piperidine-2,3,4,5-tetrol

1.2 Other means of identification

Product number -
Other names Galactostatin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:107537-94-0 SDS

107537-94-0Relevant articles and documents

Total Synthesis of (+)-Galactostatin. An Illustration of the Utility of the Thiazole-Aldehyde Synthesis

Dondoni, Alessandro,Perrone, Daniela

, p. 4749 - 4754 (2007/10/02)

The natural aza sugar (+)-galactostatin (+)-1 has been prepared from D-serine by sequential installation of chiral 1C and 2C units employing thiazole-based reagents.Thus, the D-serine-derived methyl ester 3 was transformed by 2-thiazolyllithium (4) into t

Synthesis of (+)-Galactostatin and (+)-1-Deoxygalactostatin utilizing L-Quebrachitol as a Chiral Building Block

Chida, Noritaka,Tanikawa, Tetsuya,Tobe, Takahiko,Ogawa, Seiichiro

, p. 1247 - 1248 (2007/10/02)

The stereoselective conversion of the naturally occurring optically active cyclitol, L-quebrachitol 1, into galactosidase inhibitors, (+)-galactostatin 2 and (+)-1-deoxygalactostatin 3 is described; the key steps in this synthesis are (i) stereoselective

Amidine, amidrazone, and amidoxime derivatives of monosaccharide aldonolactams: Synthesis and evaluation as glycosidase inhibitors

Papandreou,Tong,Ganem

, p. 11682 - 11690 (2007/10/02)

The synthesis of amidine, amidrazone, and amidoxime derivatives of D-glucono, D-mannono, and D-galactonolactams, which are potent glycosidase inhibitors, is described. With their sugar-like structures and resonance-stabilized, partially positively charged anomeric carbons, these monosaccharide analogs mimic key conformational and electrostatic features of the corresponding glycopyranosyl cations. In the D-gluco series, all three derivatives are potent inhibitors of sweet almond β-glucosidase. Levels of inhibition remain nearly constant despite a 105 change in basicity, indicating that conformational flattening of the hydrolysis intermediate is more important for transition-state binding by the enzyme than charge development. The same D-gluco derivatives also interact with mannose- and galactose-processing enzymes. Considerably weaker inhibition is observed with 1β-amino-1-deoxynojirimycin, which embodies similar endocyclic and exocyclic nitrogens in an undistorted chair conformation. In the D-manno series, the amidrazone and amidoxime are potent inhibitors of jackbean α-mannosidase, mung bean α-mannosidase, fungal β-mannosidase, Golgi α-mannosidase I, α-mannosidase II, and soluble (or endoplasmic reticulum) α-mannosidase. The mannoamidrazone also inhibits Golgi α-mannosidase I and the endoplasmic reticulum mannosidase in vivo. In the D-galacto series, significant inhibition of almond β-glucosidase, bovine liver β-galactosidase, and green coffee bean α-galactosidase is observed, but little or no inhibition of amyloglucosidase.

Stereocontrolled Total Synthesis of Galactostasin from Serine

Dondoni, Alessandro,Merino, Pedro,Perrone, Daniela

, p. 1576 - 1578 (2007/10/02)

An efficient stereoselective total synthesis of (-)-galactostasin (-)-1 from N-tert-butoxycarbonyl-2,3-isopropylidene L-serine methyl ester (21percent overall yield) is described via thiazole intermediates serving as protected aldehydes; the parallel synt

SYNTHESIS OF (+)-GALACTOSTATIN

Aoyagi, Sakae,Fujimaki, Satoshi,Yamazaki, Naoki,Kibayashi, Chihiro

, p. 783 - 787 (2007/10/02)

The chiral synthesis of (+)-galactostatin (3), a new β-galactosidase inhibitor, has been achieved, in which the key step involved a diastereoselective epoxidation of the allylic alcohol (4) derived from L-tartaric acid.

Synthesis of 5-amino-5-deoxy-D-galactopyranose and 1,5-dideoxy-1,5-imino-D-galactitol, and their inhibition of alpha- and beta-D-galactosidases.

Legler,Pohl

, p. 119 - 129 (2007/10/02)

A 12-step route is presented starting from 1,2:5,6-di-O-isopropylidene-alpha-D-glucofuranose for the preparation of the title compounds and their L-altro analogues. Their synthesis is based on the reduction with Raney nickel of a protected 5-hydroxyimino derivative of L-arabino-hexofuranos-5-ulose, with the following improvements for the preparation of a D-galactofuranose derivative: oxidation at C-3 with pyridinium dichromate-acetic anhydride, stereospecific reduction of a 3-O-acetyl-hex-3-enofuranose intermediate to the D-gulo derivative, and inversion at C-3 of its 3-tosylate with tetrabutylammonium acetate in chlorobenzene. alpha-D-Galactosidase from coffee beans and from Escherichia coli and beta-D-galactosidase from E. coli and Aspergillus wentii were inhibited with Ki values that ranged from 0.0007 to 8.2 microM. Formation of the enzyme-inhibitor complexes with the D-galactose analogue was on the time-scale of minutes, whereas the D-galactitol analogue showed a slow approach to the inhibition only with alpha-D-galactosidase from coffee beans and beta-D-galactosidase from A. wentii. N-Alkylation of the D-galactitol analogue was detrimental to the inhibition except for beta-D-galactosidase from E. coli and beta-D-glucosidase from almonds, but, even with these enzymes, the observed affinity enhancements were 10(2) to 10(3)-times smaller than those of N-alkylated D-galactosylamine and D-glucosylamine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 107537-94-0